Edesa Biotech (EDSA) Other Gross PP&E Adjustments (2016 - 2022)

Edesa Biotech's Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$39037.0 for Q2 2022.

  • For Q2 2022, Other Gross PP&E Adjustments rose 42.9% year-over-year to -$39037.0; the TTM value through Jun 2022 reached -$39037.0, up 42.9%, while the annual FY2021 figure was -$47729.0, 60.11% up from the prior year.
  • Other Gross PP&E Adjustments for Q2 2022 was -$39037.0 at Edesa Biotech, up from -$59863.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $46500.0 in Q2 2019 and bottomed at -$475373.0 in Q1 2019.
  • The 5-year median for Other Gross PP&E Adjustments is -$119661.0 (2020), against an average of -$174328.5.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 111.36% in 2019 before it tumbled 377.43% in 2020.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$403598.0 in 2018, then skyrocketed by 59.67% to -$162759.0 in 2019, then surged by 33.6% to -$108065.0 in 2020, then grew by 27.85% to -$77964.0 in 2021, then surged by 49.93% to -$39037.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Other Gross PP&E Adjustments are -$39037.0 (Q2 2022), -$59863.0 (Q1 2022), and -$77964.0 (Q4 2021).